The first biological approved to treat systemic lupus erythematosus

Affiliations

Comment

Christoph Fiehn. Immunotherapy. 2011 Nov.

. 2011 Nov;3(11):1293-4.

doi: 10.2217/imt.11.127.

¹ ACURA Centre for Rheumatic Diseases, Rotenbachtalstr. 5, 76532 Baden-Baden, Germany. c.fiehn@acura-kliniken.com

No abstract available

Comment on

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial.
Navarra SV, Guzmán RM, Gallacher AE, Hall S, Levy RA, Jimenez RE, Li EK, Thomas M, Kim HY, León MG, Tanasescu C, Nasonov E, Lan JL, Pineda L, Zhong ZJ, Freimuth W, Petri MA; BLISS-52 Study Group. Navarra SV, et al. Lancet. 2011 Feb 26;377(9767):721-31. doi: 10.1016/S0140-6736(10)61354-2. Epub 2011 Feb 4. Lancet. 2011. PMID: 21296403 Clinical Trial.